日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer

醉茄素 A 可增强免疫检查点阻滞剂治疗非小细胞肺癌的有效性

Roukiah Khalil, Ryan J Green, Kavya Sivakumar, Payal Varandani, Srinivas Bharadwaj, Shyam S Mohapatra, Subhra Mohapatra

Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model

光神霉素 A 与免疫检查点抑制剂联合治疗小鼠原位移植模型中的结肠直肠癌

Rinku Dutta, Roukiah Khalil, Karthick Mayilsamy, Ryan Green, Mark Howell, Srinivas Bharadwaj, Shyam S Mohapatra, Subhra Mohapatra

SARS-CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

SARS-CoV-2 免疫发病机制及多种疫苗和疗法的潜力:机遇与挑战

McGill, Andrew R; Kahlil, Roukiah; Dutta, Rinku; Green, Ryan; Howell, Mark; Mohapatra, Subhra; Mohapatra, Shyam S

Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway

放线菌素 D 与替米沙坦联合作用通过 Wnt/β-catenin 通路靶向肺癌干细胞

Ryan Green, Mark Howell, Roukiah Khalil, Rajesh Nair, Jiyu Yan, Elspeth Foran, Sandhyabanu Katiri, Jit Banerjee, Mandip Singh, Srinivas Bharadwaj, Shyam S Mohapatra, Subhra Mohapatra

Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis

肺癌细胞通过上调胆固醇合成在表皮生长因子受体酪氨酸激酶抑制剂暴露下存活

Mark C Howell, Ryan Green, Roukiah Khalil, Elspeth Foran, Waise Quarni, Rajesh Nair, Stanley Stevens, Aleksandr Grinchuk, Andrew Hanna, Shyam Mohapatra, Subhra Mohapatra